Jeremy Mason
Jeremy Mason
Assistant Professor of Research, University of Southern California
Verified email at usc.edu
Title
Cited by
Cited by
Year
Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model
PK Newton, J Mason, K Bethel, L Bazhenova, J Nieva, L Norton, P Kuhn
Cancer research 73 (9), 2760-2769, 2013
722013
A stochastic Markov chain model to describe lung cancer growth and metastasis
PK Newton, J Mason, K Bethel, LA Bazhenova, J Nieva, P Kuhn
PloS one 7 (4), e34637, 2012
682012
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites
PK Newton, J Mason, N Venkatappa, MS Jochelson, B Hurt, J Nieva, ...
NPJ breast cancer 1 (1), 1-9, 2015
282015
The prisoner’s dilemma as a cancer model
J West, Z Hasnain, J Mason, PK Newton
Convergent science physical oncology 2 (3), 035002, 2016
242016
The prisoner’s dilemma as a cancer model
J West, Z Hasnain, J Mason, PK Newton
Convergent science physical oncology 2 (3), 035002, 2016
242016
Entropy, complexity and Markov diagrams for random walk cancer models
PK Newton, J Mason, B Hurt, K Bethel, L Bazhenova, J Nieva, P Kuhn
Scientific reports 4 (1), 1-11, 2014
212014
Adrenal metastases in lung cancer: clinical implications of a mathematical model
L Bazhenova, P Newton, J Mason, K Bethel, J Nieva, P Kuhn
Journal of Thoracic Oncology 9 (4), 442-446, 2014
172014
Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients
Z Hasnain, J Mason, K Gill, G Miranda, IS Gill, P Kuhn, PK Newton
PloS one 14 (2), e0210976, 2019
122019
Liquid biopsy in colorectal carcinoma: clinical applications and challenges
D Kolenčík, SN Shishido, P Pitule, J Mason, J Hicks, P Kuhn
Cancers 12 (6), 1376, 2020
42020
Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer
GK In, J Mason, S Lin, PK Newton, P Kuhn, J Nieva
Convergent science physical oncology 3 (3), 035002, 2017
22017
Abstract PD2-07: Prediction of CDK inhibitor efficacy in ER+/HER2-breast cancer using machine learning algorithms
J Mason, Y Gong, L Amiri-Kordestani, S Wedam, JJ Gao, H Singh, ...
Cancer Research 80 (4 Supplement), PD2-07-PD2-07, 2020
12020
A Markov chain model of a longitudinal breast cancer data set.
PK Newton, JJ Nieva, P Kuhn, L Norton, EA Comen, J Mason, ...
Journal of Clinical Oncology 32 (15_suppl), 11040-11040, 2014
12014
A stochastic Markov chain model to describe cancer metastasis
J Mason
University of Southern California, 2013
12013
An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients.
Y Gong, J Mason, YL Shen, E Chang, D Kazandjian, GM Blumenthal, ...
Journal of Clinical Oncology 38 (15_suppl), 9541-9541, 2020
2020
Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model
T Fujii, J Mason, A Chen, P Kuhn, WA Woodward, D Tripathy, PK Newton, ...
The oncologist 24 (10), 1322-1330, 2019
2019
Pathways of metastatic bladder cancer from a longitudinal patient data set
JM Mason, Z Hasnain, G Miranda, K Gill, PK Newton, IS Gill, P Kuhn
Cancer Research 78 (13 Supplement), 4261-4261, 2018
2018
Markov chain models of cancer metastasis
J Mason, PK Newton
bioRxiv, 263350, 2018
2018
Adrenal metastases in lung cancer: Clinical implications of a mathematical model
JM Mason, AM Ciccarella, L Marx-Rubiner, L Bazhenova, PK Newton, ...
Cancer Research 77 (13 Supplement), 4532-4532, 2017
2017
Predicting Hepatocellular Carcinoma in Hepatitis C Patients by Analysis of APRI Score Progression Pattern
JM Mason, P Richardson, F Kanwal, PK Newton, P Kuhn, JR Kramer
HEPATOLOGY 63 (1 SUPP), 399A-400A, 2016
2016
Spatiotemporal progression patterns in metastatic lung cancer treated with bevacizumab
JM Mason, PK Newton, GK In, S Lin, P Kuhn, JJ Nieva
Cancer Research 76 (14 Supplement), 2711-2711, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20